2,3,4',5-四羟基二苯乙烯-2-O-β-D-葡萄糖苷对大鼠动脉球囊损伤模型中新生内膜形成的影响及其可能机制。
The effect of 2,3,4',5-tetrahydroxystilbene-2-0-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms.
机构信息
Department of Pharmacology, Division of Medicine, Nantong University Medical College, 19 Qi Xiu Road, Nantong 226001, China.
出版信息
Eur J Pharmacol. 2013 Jan 5;698(1-3):370-8. doi: 10.1016/j.ejphar.2012.11.019. Epub 2012 Nov 21.
2,3,4',5-tetrahydroxystilbene-2-0-β-D glucoside (TSG) has been recognized to suppress the proliferation of vascular smooth muscle cells (VSMCs). The aim of the present study was to determine whether TSG inhibits neointimal hyperplasia in a rat carotid arterial balloon injury model. Balloon injury was induced in the left common carotid artery of rats. TSG (30, 60, 120 mg/kg/day) was treated from 3 days prior to, until 14 days after the induction of balloon injury. The ratio of intima-to-media was significantly reduced in the TSG-treated rats at 14 days after the induction of injury, which was associated with reduced expressions of proliferating cell nuclear antigen (PCNA), α-smooth muscle actin (α-SMA) and platelet-derived growth factor-BB (PDGF-BB), as markers of VSMCs proliferation and migration. Additionally, TSG significantly inhibited PDGF-BB induced cell migration in cultured VSMCs. Furthermore, we explored the underlying mechanisms for such effects of TSG. The result showed that TSG markedly reduced balloon injury-induced AKT, extracellular signal-regulated kinase (ERK1/2) and nuclear factor kappaB (NF-κB) activation as well as mRNA expressions of c-myc, c-fos and c-jun, which is important signal pathway for VSMCs proliferation. And in both vivo and vitro model, TSG markedly regulated matrix metalloproteinase-2, 9 expressions and collagen I, III expressions, which are key factors in extracellular matrix for VSMCs migration. These results suggest that the anti-proliferative and anti-migrative effects of TSG on VSMCs could help to explain the beneficial effects of TSG on neointima hyperplasia induced by balloon injury.
2,3,4',5-四羟基二苯乙烯-2-O-β-D 葡萄糖苷(TSG)已被证实可抑制血管平滑肌细胞(VSMCs)的增殖。本研究旨在确定 TSG 是否可抑制大鼠颈动脉球囊损伤模型中的新生内膜增生。在大鼠左侧颈总动脉中诱导球囊损伤。TSG(30、60、120 mg/kg/天)从诱导球囊损伤前 3 天开始治疗,直到损伤后 14 天。损伤后 14 天,TSG 治疗组的内膜与中膜比显著降低,这与增殖细胞核抗原(PCNA)、α-平滑肌肌动蛋白(α-SMA)和血小板衍生生长因子-BB(PDGF-BB)的表达降低有关,这些标志物可反映 VSMCs 的增殖和迁移。此外,TSG 还显著抑制了 PDGF-BB 诱导的培养 VSMCs 的迁移。此外,我们还探讨了 TSG 产生这种作用的潜在机制。结果表明,TSG 显著降低了球囊损伤诱导的 AKT、细胞外信号调节激酶(ERK1/2)和核因子 kappaB(NF-κB)的激活以及 c-myc、c-fos 和 c-jun 的 mRNA 表达,这些是 VSMCs 增殖的重要信号通路。在体内和体外模型中,TSG 均显著调节基质金属蛋白酶-2、9 的表达以及胶原 I、III 的表达,这些是 VSMCs 迁移的细胞外基质的关键因素。这些结果表明,TSG 对 VSMCs 的抗增殖和抗迁移作用可能有助于解释 TSG 对球囊损伤诱导的新生内膜增生的有益作用。